GLP-1 Drug Fails to Improve Alzheimer's Symptoms, Scientists Remain Hopeful Novo Nordisk's Rybelsus (semaglutide) setback in slowing cognitive decline This past week, Novo Nordisk revealed that its old oral version of semaglutide, Rybelsus, failed to slow cognitive decline in Alzheimers patients significantly
Zhonghua Yi Xue Za Zhi 91 (39), 27972800
This is why routine drug screens almost never detect them
When motility slows, this cleaning mechanism becomes less effective, which is one reason researchers have long linked disrupted MMC activity to conditions like SIBO , or small intestinal bacterial overgrowth. Can GLP-1 Medications Cause SIBO? This is one of the most important questions in this space
Notably, C57BL/6 male mice that received sulforaphane in conjunction with depression-inducing lipopolysaccharide, exhibited lower depressive behaviours on the tail-suspension test and forced swimming test compared to those that did not receive sulforaphane (Zhang et al., 2017)
In addition to, or in place of a walker, physical therapy, cane, or scooter, Dr